Firm record

Abdi Ibrahim Pharmaceuticals

◇Private·Turkey·GICS Pharmaceuticals, Biotechnology and Life Sciences·LEI 789000SMET71WHR2US38

This is a partial record assembled from open public datasets (WBA, Net Zero Tracker, SBTi, TPI, CDP). Reverberate's deeper extraction layer covers a curated cohort of firms — see the full directory for firms with verified financial + multi-year disclosure depth.

Partial profile

We haven't fully researched Abdi Ibrahim Pharmaceuticals yet.

Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.

We’ll only use your email to notify you about this request.

Climate action evidence

1 record · 1 source

Carbon credits retired

1 tCO2e

1 retirement · FY2021–2021 · third-party verified

By credit quality

Avoidance / reductions1 tCO2e(100%)

Retirement records(top 1 by volume of 1)

2021 A-Gas V8 · acr1 tCO2e

Renewable electricity

No third-party REC retirements on file and no self-reported renewable share disclosed.

Sources

· berkeley_voluntary_registry

Registry retirements are direct evidence; commitments are forward-looking pledges. EPA snapshot covers FY2019–FY2020.

Targets & commitments6

Source	Type	Scope	Base	Target year	Value	Status
sbti	near_term	Scope 1 + 2	2019	2034	74.8%	1.5°C
sbti	long_term	3	2019	2050	97%	—
sbti	—	—	—	—	—	—
sbti	near_term	3	2019	2034	66.4%	—
sbti	net_zero	Scope 1 + 2 + 3	2019	2050	—	1.5°C
sbti	long_term	Scope 1 + 2	2019	2050	90%	1.5°C

Identifiers

lei	789000SMET71WHR2US38
sbti_id	40006779
Reverberate ID	bf34ddf2…